News & Events
IDWeek 2021 Virtual Conference
Healix is once again a proud Bronze Sponsor for IDWeek 2021—the premier show for infectious diseases. IDWeek is a forum for health professionals of varied backgrounds to collaborate, cooperate, and learn from each other’s expertise. With so many common issues and...
Florida Society of Neurology Annual Meeting
Our team is excited to attend the 2021 Annual Meeting of the Florida Society of Neurology, September 24-26, 2021, in Orlando, Florida. Join us at the Rosen Centre Hotel to learn more about our Infusion Therapy Solutions for your practice. Healix is the premier...
COVID-19 Pandemic Initial Impact on Outpatient Intravenous Antibiotic Therapy
Introduction The COVID-19 pandemic has dramatically affected the provision of healthcare services in the US. Routine and elective healthcare services experienced sharp declines due to COVID transmission fears, regional stay-at-home orders, and bans on many elective...
COVID-19 Pandemic Impact on Infusion Utilization
Physician office infusion centers deliver lower cost and higher adherence -- even during a pandemic. Spend on infused drugs is expected to grow by nearly 65% to $155B in 2023. Managing this growing spend will require access to cost-effective and high-quality...
Happy National Pharmacy Week (October 18-24) from Healix!
In celebration of Pharmacy Week 2020, the entire team at Healix would like to sincerely thank all pharmacists, pharmacy technicians, and pharmacy personnel for their service and dedication to the pharmacy profession. Despite the many challenges that the COVID-19...
American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting
Virtual Event Healix is proud to participate in clinical research at the 2020 American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting. Visit our ePoster at this year's virtual conference, available online beginning November 13, 2020, through...
American College of Gastroenterology (ACG) Annual Meeting
Virtual Event Healix is a proud participant of collaborative research with GI Alliance at the 2020 American College of Gastroenterology (ACG) Annual Meeting. Visit the poster presentation at this year’s virtual conference October 23 – 28, 2020. Real-World...
IDWeek 2020
Virtual Event Healix is a proud exhibitor at IDWeekTM 2020! Uniquely focused in infectious disease (ID) and supporting over 300 ID physicians across the country, we are the nation's leader in providing physician office-based infusion services. Focused on patient...
Immunoglobulin National Society (IgNS) 9th National Conference 2020
Virtual Event Healix is excited to present our research data on Cutaquig® at the Immunoglobulin National Society (IgNS) 9th National Conference 2020. Speak with presenting author Lucinda J. Van Anglen, B.S., Pharm.D., during the IgNS Poster Session on Monday,...
Healix Demonstrates Hospital Avoidance with Provision of Outpatient Antimicrobial Therapy (OPAT): A Leader in the Field for Over 30 Years
SUGAR LAND, TX – (July 9, 2020) Healix Infusion Therapy, LLC has demonstrated success in achieving hospital avoidance when providing outpatient antimicrobial therapy (OPAT) to patients with serious infections through physician offices. Healix manages over 70...
Healix Announces First Real-World Study of Immune Globulin Subcutaneous 16.5% (Cutaquig®) Featured in the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
SUGAR LAND, TX – (May 7, 2020) Healix Infusion Therapy is pleased to announce that its collaborative research study regarding Immune Globulin Subcutaneous 16.5% (Cutaquig®) is now accessible in the AAAAI Annual Meeting Virtual Poster Hall. The study by authors...
Happy National Nurses Week (May 6-12) from Healix!
The team at Healix would like to recognize and thank nurses across the nation for their dedication to the nursing profession and the time they sacrifice away from their loved ones to care for those in need. Nurses play a critical role not only in our healthcare...
Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
SUGAR LAND, TX – (March 20, 2020) Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in the leading scientific journal, Open Forum Infectious Diseases. This real-world multicenter study demonstrated successful prevention of...
Thank You Healthcare Heroes!
The team at Healix would like to thank all the healthcare heroes who are on the front lines treating patients during this unprecedented time with the COVID-19 crisis. We know you are faced with new challenges every day, and we are sincerely grateful, now more than...
State of Texas Association of Rheumatologists (STAR)
Houston, TX Get to know Healix on February 28, 2020, at the State of Texas Association of Rheumatologists (STAR) Annual Meeting in Houston, TX. Visit the Healix team to learn how we have continually supported practices through our robust infusion center management...